Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $187.2 million.

  • Mesoblast's Total Liabilities fell 82.47% to $187.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $187.2 million, marking a year-over-year decrease of 82.47%. This contributed to the annual value of $187.2 million for FY2025, which is 82.47% down from last year.
  • Latest data reveals that Mesoblast reported Total Liabilities of $187.2 million as of Q2 2025, which was down 82.47% from $192.1 million recorded in Q4 2024.
  • Mesoblast's 5-year Total Liabilities high stood at $192.1 million for Q4 2024, and its period low was $161.6 million during Q4 2023.
  • Moreover, its 5-year median value for Total Liabilities was $166.4 million (2021), whereas its average is $170.3 million.
  • In the last 5 years, Mesoblast's Total Liabilities crashed by 1137.21% in 2021 and then skyrocketed by 1888.04% in 2024.
  • Mesoblast's Total Liabilities (Quarter) stood at $168.9 million in 2021, then dropped by 0.52% to $168.1 million in 2022, then dropped by 3.87% to $161.6 million in 2023, then rose by 18.88% to $192.1 million in 2024, then dropped by 2.51% to $187.2 million in 2025.
  • Its last three reported values are $187.2 million in Q2 2025, $192.1 million for Q4 2024, and $188.8 million during Q2 2024.